AIN
Next Generation Oncology

Next Generation Oncology

location_on Japan

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Our technology enhances oncology imaging by converting 2D images into 3D with depth in real time, improving diagnostic accuracy and treatment precision.

Highlights

  • Massive Market Opportunity. The market to over $100B by 2030.
  • Convert 2D medical images into 3D in real time Technology Advantage.
  • Clear Clinical Impact with shorter exam times, reduced radiation time.
  • Strong Business Model with Licensing and OEM partnerships
  • Execution & Growth Path become the leader in AI-driven oncology imaging.in

Overview

Target A$1,500,000
Minimum A$800
Investment Raised A$60,000
Previous Rounds A$600,000
Stage MVP/Finished Product
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects